BioRestorative Therapies Schedules Pre-IND Meeting with FDA | Publicwire

BioRestorative Therapies, Inc. (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announced that a Pre-IND (Investigational New Drug) meeting with the Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration has been scheduled for December 19, 2014.
http://bit.ly/1r2zEOR